BSD Medical Corporation (BSDM)’s Investor and Analyst Conference Call Transcript

Below is the transcript of the BSD Medical Corporation (NASDAQ:BSDM)’s Investor and Analyst Conference Call, held on January 16th, 2015 at 3:00 p.m ET.

BSD Medical Corporation (NASDAQ:BSDM) (the “Company”) develops, manufactures, markets and services medical systems that deliver precision-focused radio frequency (RF) or microwave energy into diseased sites of the body, heating them to specified temperatures as required by a variety of medical therapies.

Company Representatives:

Clint Carnell – Chief Executive Officer

William S. Barth – Chief Financial Officer

Ms. Tricia Ralph – Financial Profiles

Analysts:

Dan Yankovich – Maxim Group

Operator

Good day, and welcome to the BSD investor and analyst conference call. All participants, will be on listen only mode. If you need assistance, please signal conference specialist by pressing the star key followed by zero. After today’s presentation, there will be an opportunity to ask questions. To ask a question you may press star, then 1 on your cell phone. To draw your question, please press star then 2. Please note, this event is being recorded. I will now extend the conference call over to Ms. Tricia Ralph of Financial Profiles. Ms Ralph, the floor is yours Ma’am.

Ms. Tricia Ralph

Thank you! Hello everyone, and thank you for all joining us today. As you may have seen this morning, we filed our 10 Q for the first quarter yesterday, and issued our financial results press release. With us today, from management our CEO Clint Carnell and CFO William Bellfard. Now, before we start I would like to remind you that comments made during this conference call that are not based on historical facts are fore looking statements within the meaning of private securities litigation’s reform acts of 1995. These formats looking statements may include statements relating to our business objectives, plans, strategies and future financial performance among others. Many of these statements involve known and unknown risks and uncertainties, which could cause actual results to differ materially from those expected results, performance or achievements expressed or implied. By statements made herein.

These risks include operational, financial and legal risks and are more fully described in the risk factor section of our annual report on form 10K for the year ended August 31, 2014 and in our quarterly reports on form 10Q. All of our plans and objectives made in this conference call presentation are based on management’s current expectation. But many such expectations are based on economic, clinical and regulatory uncertainties and must differ materially from our actual results. We assume no obligations to update any fore looking statements or information.

I’d now like to turn the call over to Clint Carnell. He’s Executive Officer of the LT medical corporation. Clint, please go ahead.